Cambridge Healthtech Institute

Join us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by Patrick A. Baeuerle, Ph.D., CSO, Senior Vice President, R&D, Micromet, Inc.

Join us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by: Puja Sapra, Ph.D., Director, Bioconjugates, Oncology Research Unit, Pfizer Biotherapeutics.

Join us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by: Bob Lutz, Ph.D., VP, Translational R&D, ImmunoGen, Inc.

Join us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by: Norman J. Maitland, Ph.D., Chief Scientific Officer, Procure Therapeutics Ltd.

Join 150+ delegates involved in IT and informatics at pharma, biotech & academic institutions at CHI’s Molecular Med TRI-CON 2012 event on Feb. 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. www.TriConference.com/IRD.

Delegates now have the option to choose from 3 moderated breakout discussion groups in the exhibit hall at this conference that is set for February 21-23, Moscone North Convention Center, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Hear breakthroughs in the field of pathology such as predictive cancer biomarkers, decoding cancer molecular profiles, next generation sequencing, circulating tumor cells, etc. View final agenda at www.healthtech.com/tdx.

Event Focus will be Predicting Biological and Kinetic Profiles from Structure

Delegates now have the option to choose from 3 moderated breakout discussion groups in the exhibit hall at this conference that is set for February 21-23, Moscone North Convention Center, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Agenda Announcement and Registration Reminder for CHI’s Eighth Annual PEGS the essential protein engineering summit, April 30 – May 4, Boston, MA